TerryAVikMD

Pediatric Hematology & Oncology • Indianapolis, IN

Pediatric Coagulation Disorder Hematology, Pediatric Hematologic Oncology, Pediatric Solid Tumor Oncology

Professor of Pediatrics, Indiana University

Join to view full profile

Dr. Vik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vik's full profile

Already have an account?

Office
705 Riley Hospital Dr
Roc 4340
Indianapolis, IN 46202
Phone+1 317-944-8784

Fax+1 317-944-3107

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1986 - 1991
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1983 - 1986
Johns Hopkins University School of MedicineClass of 1983

Certifications & Licensure

IN State Medical License 1991 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2016
Indianapolis Monthly Castle Connolly, 2007-2016
America's Top Doctors for Cancer Castle Connolly, 2005-2016

Clinical Trials

Childhood Cancer Survivor Study Start of enrollment: 1995 Jan 05
Recruiting
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

102 citations
Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study.
Daniel A. Mulrooney, Douglas C. Dover, Suwen Li, Yutaka Yasui, Kirsten K. Ness
Cancer. 2008-05-01
145 citations
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
Kent A. Robertson, Grzegorz Nalepa, Feng Chun Yang, Daniel C. Bowers, Chang Y. Ho
The Lancet. Oncology. 2012-12-01
58 citations
Risk-prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds-Clot clinical Decision Rule.
Anjali Sharathkumar, Arash Mahajerin, L. Heidt, K. Doerfer, Mark E. Heiny
Journal of Thrombosis and Haemostasis. 2012-07-01

Press Mentions

Put It on the Board, 5/17May 18th, 2017
Riley Hospital Seniors Hold Graduation CelebrationJune 24th, 2016

Grant Support

Childhood Leukemia in Kenya Identified Through Malaria Slide ReviewAlex's Lemonade Stand Foundation2012–Present
Sirolimus With Etoposide In Children With Refractory Solid TumorsNational Center For Research Resources2005
S6 Kinase Activation, Regulation, And OrganizationEunice Kennedy Shriver National Institute Of Child Health &Human Development1991–1993
S6 Kinase Activation, Regulation, And OrganizationEunice Kennedy Shriver National Institute Of Child Health &Human Development1989–1990